View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
May 6, 2021

EU companies on China’s shopping list

By Paul Dennis

6 May

Alicia Garcia Herrero, Chief Economist for Asia Pacific at Natixis, shared an article on how China’s M&A activity has rebounded strongly towards the end of 2020.

The Covid-19 pandemic and related restrictions impacted the country’s outbound M&A activity in early 2020, showing a decline by more than half in value compared to 2019.

However, M&A activity in China rebounded towards the end of 2020 with specific focus on European industrial companies.

The rebound was mainly driven by two deals including Tencent’s acquisition of a 10% stake in Universal Music and Shanghai RAAS’s acquisition of 45% of Grifols Diagnostic Solutions.

China’s interest in exploring global opportunities and its search for technology upgrades are primary drivers for rise in M&A activity.

Activity may not return to the record levels witnessed in 2016-2017 but may return to 2019-2020 levels in 2021.

Companies in the European Union are expected to remain the country’s main targets.

Read more

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology